11 Good Energy, Inc. ELVN 深 滬
交易中 09-20 13:52:53 美东时间
22.79
-0.280
-1.21%
華盛通- 最 高23.06
- 今 開22.92
- 成交量 19.78万股
- 最 低 22.39
- 昨 收 23.07
- 總市值 9.42亿
- 52周最高 27.6731
- 市盈率 靜 --
- 換手率 0.48%
- 52周最低 9.80
- 委 比 -98.36%
- 總股本 4134.76万
- 歷史最高 250.84
- 量 比 1.97
- 振 幅 2.90%
- 歷史最低 3.896
- 每 手 1
- 風險率 4.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Enliven Therapeutics GAAP EPS of -$0.54 beats by $0.02
Enliven Therapeutics press release (NASDAQ:ELVN): Q1 GAAP EPS of -$0.54 beats by $0.02. Balance sheet with $321 million in cash, cash equivalents and marketable securities, which is expected to provid...
05-15 18:24
Enliven Therapeutics files to sell 6.43M shares for holders
Enliven Therapeutics (NASDAQ:ELVN) on Thursday filed a prospectus related to the proposed resale of about 6.43M shares of its common stock by selling stockholders. This prospectus is not an offer to s...
04-19 04:57
Enlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals among healthcare movers
Gainers: Rallybio (RLYB) +84%. Eliem Therapeutics (ELYM) +59%. Alpine Immune Sciences (ALPN) +36%. Candel Therapeutics (CADL) +28%. Enliven Therapeutics (ELVN) +29%. Losers: Aptevo Therapeutics (APVO)...
04-11 22:04
Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
Mizuho Securities initiates coverage on Enliven Therapeutics. Expectations high for late 2024 Phase 1 results. Enliven poised to revolutionize CML treatment, addressing current TKI limitations. Mizuho bullish with Buy rating, $34 price target. ELVN's trading value suggests conservative estimation compared to CML market potential.
04-10 02:26
Owning 36% Shares,institutional Owners Seem Interested in Enliven Therapeutics, Inc. (NASDAQ:ELVN),
Key Insights Significantly high institutional ownership implies Enliven Thera...
04-09 20:02
美股牛股 | FUSN一夜翻倍！获阿斯利康豪气收购；SPIR宣布与英伟达合作
Fusion制药一夜翻倍！获阿斯利康20亿美元豪气收购；又一“英伟达概念股”火了！Spire Global隔夜暴涨30%>>
03-20 18:50
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday.
03-19 22:03
Enliven Therapeutics Announces $90M Private Placement Financing; Provides Pipeline Updates
Financing includes participation from new and existing investorsNet proceeds, along with existing cash, cash equivalents and marketable securities, are expected to extend cash runway into late 2026 and through multiple
03-19 20:36
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 201 stocks hit new 52-week lows.
2023-08-15 01:48
Enliven Therapeutics Q1 EPS $(0.80) Misses $(0.63) Estimate
Enliven Therapeutics (NASDAQ:ELVN) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.63) by 26.98 percent. This is a 64.29 percent increase over losses of $(2.24) per share
2023-05-12 04:37
